PDCD1 and cancer: On the other hand, it has been proposed that patients with ‘inflamed tumors’ display high levels of PD‐L1 expression on cancer and tumor‐infiltrating cells, harbor activated T cells and they are responsive to PD‐1 pathway blockade.